Erythromycin Stearate

   
Google
 
Web NewDrugInformation.com

Erythromycin Stearate


Drug - Erythromycin Stearate
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Erythromycin Stearate
Multiple ingredients are in alphabetical order.

Strength - EQ 500MG BASE
The potency of the active ingredient(s), Erythromycin Stearate. May repeat for multiple part products.

Applicant - LEDERLE
The firm name holding legal responsibility for Erythromycin Stearate. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 062089
The FDA assigned number to Erythromycin Stearate. Format is nnnnnn.

Product Number - 002
The FDA assigned number to identify Erythromycin Stearate. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Erythromycin Stearate was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Erythromycin Stearate. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Erythromycin Stearate is in. Format is RX, OTC, DISCN.

Applicant Full Name - Lederle Laboratories Div American Cyanamid Co
The full name of the firm holding legal responsibility for the new application of Erythromycin Stearate.

Erythromycin Stearate